Hot Lines: Targeting iron deficiency in heart failure
Previous studies have shown that ferric carboxymaltose (FCM) improves symptoms, quality of life and exercise capacity in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency;1,2 however, further evidence is needed regarding its effects on clinical events.